This trial will test a new procedure to lower eye pressure in people with early to moderate stage primary open-angle glaucoma who are also having cataract surgery.
1 Primary · 1 Secondary · Reporting Duration: 24 Month
318 Total Participants · 0 Treatment Group
Primary Treatment: Treatment · No Placebo Group · N/A
Age 18+ · All Participants · 7 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:California | 100.0% |
65+ | 100.0% |
Did not meet criteria | 100.0% |